UB Paderborn / Katalog / Suche / in CDI

Posaconazole Plasma Concentrations in Juvenile Patients with Invasive Fungal Infection

Antimicrobial Agents and Chemotherapy, 2007-03, Vol.51 (3), p.812-818

2007

Volltextzugriff (PDF)

Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects

Journal of clinical pharmacology, 2018-07, Vol.58 (7), p.897-904

2018

Volltextzugriff (PDF)

Hypothalamic-Pituitary-Adrenal Axis Effects of Mometasone Furoate/Formoterol Fumarate vs Fluticasone Propionate/Salmeterol Administered Through Metered-Dose Inhaler

Chest, 2013-12, Vol.144 (6), p.1795-1802

2013

Volltextzugriff (PDF)

Effect of a Nutritional Supplement on Posaconazole Pharmacokinetics following Oral Administration to Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2006-05, Vol.50 (5), p.1881-1883

2006

Volltextzugriff (PDF)

Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients

European journal of clinical pharmacology, 2012-04, Vol.68 (4), p.415-418

2012

Volltextzugriff (PDF)

Evaluation of the exposure equivalence of oral versus intravenous temozolomide

Cancer chemotherapy and pharmacology, 2010-03, Vol.65 (4), p.727-734

2010

Volltextzugriff (PDF)

Pharmacokinetics of desloratadine in children between 2 and 11 years of age

British journal of clinical pharmacology, 2007-05, Vol.63 (5), p.534-540

2007

Volltextzugriff (PDF)

Pharmacokinetics and safety of single-dose ribavirin in patients with chronic renal impairment

Drug Discoveries & Therapeutics, 2013/08/31, Vol.7(4), pp.158-163

2013

Volltextzugriff (PDF)

Exploring the influence of renal dysfunction on the pharmacokinetics of ribavirin after oral and intravenous dosing

Drug discoveries & therapeutics, 2014-04, Vol.8 (2), p.89-95

2014

Volltextzugriff (PDF)

Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults

British journal of clinical pharmacology, 2007-08, Vol.64 (2), p.174-184

2007

Volltextzugriff (PDF)

HPA Axis Effects of Mometasone Furoate/Formoterol (MF/F) Versus Fluticasone Propionate/Salmeterol (FP/S) Administered via Metered-Dose Inhaler (MDI

Chest, 2012-10, Vol.142 (4), p.685A-685B

2012

Volltextzugriff (PDF)

Validation of a sensitive and automated 96-well solid-phase extraction liquid chromatography–tandem mass spectrometry method for the determination of desloratadine and 3-hydroxydesloratadine in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003-07, Vol.792 (2), p.229-240

2003

Volltextzugriff (PDF)

Exploring the influence of renal dysfunction on the pharmaco-kinetics of ribavirin after oral and intravenous dosing

Drug Discoveries & Therapeutics, 2014/04/30, Vol.8(2), pp.89-95

2014

Volltextzugriff (PDF)

Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device

Clinical pharmacology in drug development, 2014-05, Vol.3 (3), p.222-228

2014

Volltextzugriff (PDF)

Simplification of Imipenem Dosing by Removal of Weight‐Based Adjustments

Journal of clinical pharmacology, 2019-05, Vol.59 (5), p.646-653

2019

Volltextzugriff (PDF)

A Model-Based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verubecestat Trials

The AAPS journal, 2022-05, Vol.24 (3), p.53-53, Article 53

2022

Volltextzugriff (PDF)

Effect of Oral Posaconazole on the Pharmacokinetics of Cyclosporine and Tacrolimus

Pharmacotherapy, 2007-06, Vol.27 (6), p.825-834

2007

Volltextzugriff (PDF)

Insulin glargine and its two active metabolites: A sensitive (16pM) and robust simultaneous hybrid assay coupling immunoaffinity purification with LC–MS/MS to support biosimilar clinical studies

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2017-09, Vol.1063, p.50-59

2017

Volltextzugriff (PDF)

Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men

Current medical research and opinion, 2007-06, Vol.23 (6), p.1415-1422

2007

Volltextzugriff (PDF)

Effect of aprepitant on the pharmacokinetics of the cyclin-dependent kinase inhibitor dinaciclib in patients with advanced malignancies

Cancer chemotherapy and pharmacology, 2012-12, Vol.70 (6), p.891-898

2012

Volltextzugriff (PDF)

Multiple-Dose Pharmacokinetics and Safety of Desloratadine in Subjects With Moderate Hepatic Impairment

Journal of clinical pharmacology, 2007-10, Vol.47 (10), p.1283-1291

2007

Volltextzugriff (PDF)

Pharmacokinetics/Pharmacodynamics of Desloratadine and Fluoxetine in Healthy Volunteers

Journal of clinical pharmacology, 2004-11, Vol.44 (11), p.1252-1259

2004

Volltextzugriff (PDF)

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

International journal of chronic obstructive pulmonary disease, 2013-01, Vol.8 (default), p.107-116

2013

Volltextzugriff (PDF)

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects

Clinical pharmacology in drug development, 2014-05, Vol.3 (3), p.229-234

2014

Volltextzugriff (PDF)

Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study

Clinical therapeutics, 2001-03, Vol.23 (3), p.451-466

2001

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Posaconazole Plasma Concentrations in Juvenile Patients with Invasive Fungal Infection

Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects

Hypothalamic-Pituitary-Adrenal Axis Effects of Mometasone Furoate/Formoterol Fumarate vs Fluticasone Propionate/Salmeterol Administered Through Metered-Dose Inhaler

Effect of a Nutritional Supplement on Posaconazole Pharmacokinetics following Oral Administration to Healthy Volunteers

Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients

Evaluation of the exposure equivalence of oral versus intravenous temozolomide

Pharmacokinetics of desloratadine in children between 2 and 11 years of age

Pharmacokinetics and safety of single-dose ribavirin in patients with chronic renal impairment

Exploring the influence of renal dysfunction on the pharmacokinetics of ribavirin after oral and intravenous dosing

Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults

HPA Axis Effects of Mometasone Furoate/Formoterol (MF/F) Versus Fluticasone Propionate/Salmeterol (FP/S) Administered via Metered-Dose Inhaler (MDI

Validation of a sensitive and automated 96-well solid-phase extraction liquid chromatography–tandem mass spectrometry method for the determination of desloratadine and 3-hydroxydesloratadine in human plasma

Exploring the influence of renal dysfunction on the pharmaco-kinetics of ribavirin after oral and intravenous dosing

Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device

Simplification of Imipenem Dosing by Removal of Weight‐Based Adjustments

A Model-Based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verubecestat Trials

Effect of Oral Posaconazole on the Pharmacokinetics of Cyclosporine and Tacrolimus

Insulin glargine and its two active metabolites: A sensitive (16pM) and robust simultaneous hybrid assay coupling immunoaffinity purification with LC–MS/MS to support biosimilar clinical studies

Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men

Effect of aprepitant on the pharmacokinetics of the cyclin-dependent kinase inhibitor dinaciclib in patients with advanced malignancies

Multiple-Dose Pharmacokinetics and Safety of Desloratadine in Subjects With Moderate Hepatic Impairment

Pharmacokinetics/Pharmacodynamics of Desloratadine and Fluoxetine in Healthy Volunteers

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects

Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study

Suchergebnisse filtern